Stay updated on Autologous BCMA CAR T-cells in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Autologous BCMA CAR T-cells in Myeloma Clinical Trial page.

Latest updates to the Autologous BCMA CAR T-cells in Myeloma Clinical Trial page
- CheckyesterdayChange DetectedA new entry 'Revision: v3.6.5' was added to the study record history, indicating a platform-level update to ClinicalTrials.gov rather than a change to the study itself.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows Revision: v3.6.4 in place of v3.6.3, indicating a small platform update that updates the displayed release version without altering core content.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedA new revision entry, v3.6.3, has been added to the study record history, and the previous revision v3.6.2 has been removed.SummaryDifference0.1%

- Check44 days agoChange DetectedNew revision entry v3.6.2 was added to the Record History, and the previous revision v3.6.0 was removed.SummaryDifference0.1%

- Check58 days agoChange DetectedNew in the history: 'No longer looking for participants' signals that the study is no longer recruiting. The version history also adds 'Revision: v3.6.0' and removes 'Revision: v3.5.5'.SummaryDifference0.6%

- Check65 days agoChange DetectedThe record history shows a new revision entry labeled v3.5.5, indicating that the ClinicalTrials.gov entry was updated since the previous version. The previous revision v3.5.4 remains in the historical log.SummaryDifference0.1%

Stay in the know with updates to Autologous BCMA CAR T-cells in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous BCMA CAR T-cells in Myeloma Clinical Trial page.